175 related articles for article (PubMed ID: 28821636)
1. Twenty-four-hour rhythmicity of circulating metabolites: effect of body mass and type 2 diabetes.
Isherwood CM; Van der Veen DR; Johnston JD; Skene DJ
FASEB J; 2017 Dec; 31(12):5557-5567. PubMed ID: 28821636
[TBL] [Abstract][Full Text] [Related]
2. Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men.
Mäntele S; Otway DT; Middleton B; Bretschneider S; Wright J; Robertson MD; Skene DJ; Johnston JD
PLoS One; 2012; 7(5):e37123. PubMed ID: 22623983
[TBL] [Abstract][Full Text] [Related]
3. Diurnal rhythms in the white adipose tissue transcriptome are disturbed in obese individuals with type 2 diabetes compared with lean control individuals.
Stenvers DJ; Jongejan A; Atiqi S; Vreijling JP; Limonard EJ; Endert E; Baas F; Moerland PD; Fliers E; Kalsbeek A; Bisschop PH
Diabetologia; 2019 Apr; 62(4):704-716. PubMed ID: 30737520
[TBL] [Abstract][Full Text] [Related]
4. Identification of human plasma metabolites exhibiting time-of-day variation using an untargeted liquid chromatography-mass spectrometry metabolomic approach.
Ang JE; Revell V; Mann A; Mäntele S; Otway DT; Johnston JD; Thumser AE; Skene DJ; Raynaud F
Chronobiol Int; 2012 Aug; 29(7):868-81. PubMed ID: 22823870
[TBL] [Abstract][Full Text] [Related]
5. [Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].
Wang LY; Wei L; Yu HY; Zhang Y; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):235-8. PubMed ID: 19552838
[TBL] [Abstract][Full Text] [Related]
6. Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes.
Ottosson F; Smith E; Gallo W; Fernandez C; Melander O
J Clin Endocrinol Metab; 2019 Oct; 104(10):4921-4930. PubMed ID: 31502646
[TBL] [Abstract][Full Text] [Related]
7. Greater blood volume and Hb mass in obese women quantified by the carbon monoxide-rebreathing method affects interpretation of iron biomarkers and iron requirements.
Cepeda-Lopez AC; Zimmermann MB; Wussler S; Melse-Boonstra A; Naef N; Mueller SM; Toigo M; Herter-Aeberli I
Int J Obes (Lond); 2019 May; 43(5):999-1008. PubMed ID: 29907846
[TBL] [Abstract][Full Text] [Related]
8. A novel time-dimension and circadian rhythm-dependent strategy for pharmacodynamic evaluation of Uncaria in the regulation of neurotransmitter circadian metabolic homeostasis in spontaneously hypertensive rats.
Sun M; Wang H; Gong L; Qi D; Wang X; Li Y; Jiang H
Biomed Pharmacother; 2020 Nov; 131():110704. PubMed ID: 32916538
[TBL] [Abstract][Full Text] [Related]
9. Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes.
Giesbertz P; Padberg I; Rein D; Ecker J; Höfle AS; Spanier B; Daniel H
Diabetologia; 2015 Sep; 58(9):2133-43. PubMed ID: 26058503
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers].
Benbaibeche H; Haffaf el M; Kacimi G; Oudjit B; Koceir E
Ann Biol Clin (Paris); 2014; 72(4):463-72. PubMed ID: 25119805
[TBL] [Abstract][Full Text] [Related]
11. Role of cardiotrophin-1 in the regulation of metabolic circadian rhythms and adipose core clock genes in mice and characterization of 24-h circulating CT-1 profiles in normal-weight and overweight/obese subjects.
López-Yoldi M; Stanhope KL; Garaulet M; Chen XG; Marcos-Gómez B; Carrasco-Benso MP; Santa Maria EM; Escoté X; Lee V; Nunez MV; Medici V; Martínez-Ansó E; Sáinz N; Huerta AE; Laiglesia LM; Prieto J; Martínez JA; Bustos M; Havel PJ; Moreno-Aliaga MJ
FASEB J; 2017 Apr; 31(4):1639-1649. PubMed ID: 28096235
[TBL] [Abstract][Full Text] [Related]
12. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.
Al-Harithy RN; Al-Ghamdi S
Ann Saudi Med; 2005; 25(4):283-7. PubMed ID: 16212119
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
[TBL] [Abstract][Full Text] [Related]
14. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes.
Al-Sulaiti H; Diboun I; Agha MV; Mohamed FFS; Atkin S; Dömling AS; Elrayess MA; Mazloum NA
J Transl Med; 2019 Oct; 17(1):348. PubMed ID: 31640727
[TBL] [Abstract][Full Text] [Related]
15. Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight.
Isherwood CM; Robertson MD; Skene DJ; Johnston JD
Endocr Connect; 2023 Nov; 12(11):. PubMed ID: 37855336
[TBL] [Abstract][Full Text] [Related]
16. Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach.
Gogna N; Krishna M; Oommen AM; Dorai K
Mol Biosyst; 2015 Feb; 11(2):595-606. PubMed ID: 25464928
[TBL] [Abstract][Full Text] [Related]
17. Disrupted circadian rhythms of body temperature, heart rate and fasting blood glucose in prediabetes and type 2 diabetes mellitus.
Gubin DG; Nelaeva AA; Uzhakova AE; Hasanova YV; Cornelissen G; Weinert D
Chronobiol Int; 2017; 34(8):1136-1148. PubMed ID: 28759269
[TBL] [Abstract][Full Text] [Related]
18. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.
Ni Y; Zhao L; Yu H; Ma X; Bao Y; Rajani C; Loo LW; Shvetsov YB; Yu H; Chen T; Zhang Y; Wang C; Hu C; Su M; Xie G; Zhao A; Jia W; Jia W
EBioMedicine; 2015 Oct; 2(10):1513-22. PubMed ID: 26629547
[TBL] [Abstract][Full Text] [Related]
19. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
